ID   G6PC_HUMAN              Reviewed;         357 AA.
AC   P35575; A1L4C0; B4E1C3; K7EL82;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 2.
DT   10-MAY-2017, entry version 167.
DE   RecName: Full=Glucose-6-phosphatase;
DE            Short=G-6-Pase;
DE            Short=G6Pase;
DE            EC=3.1.3.9;
DE   AltName: Full=Glucose-6-phosphatase alpha;
DE            Short=G6Pase-alpha;
GN   Name=G6PC; Synonyms=G6PT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=8211187; DOI=10.1126/science.8211187;
RA   Lei K.-J., Shelly L.L., Pan C.-J., Sidbury J.B., Chou J.Y.;
RT   "Mutations in the glucose-6-phosphatase gene that cause glycogen
RT   storage disease type 1a.";
RL   Science 262:580-583(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   GLYCOSYLATION AT ASN-96.
RX   PubMed=9705299; DOI=10.1074/jbc.273.34.21658;
RA   Pan C.J., Lei K.J., Chou J.Y.;
RT   "Asparagine-linked oligosaccharides are localized to a luminal
RT   hydrophilic loop in human glucose-6-phosphatase.";
RL   J. Biol. Chem. 273:21658-21662(1998).
RN   [6]
RP   ACTIVE SITES, MUTAGENESIS OF HIS-9; HIS-52; HIS-119; HIS-176; HIS-179;
RP   HIS-197; HIS-252; HIS-307 AND HIS-353, AND CHARACTERIZATION OF
RP   VARIANTS ASN-76; CYS-83 AND GLN-170.
RX   PubMed=12093795; DOI=10.1074/jbc.M201853200;
RA   Ghosh A., Shieh J.-J., Pan C.-J., Sun M.-S., Chou J.Y.;
RT   "The catalytic center of glucose-6-phosphatase. HIS176 is the
RT   nucleophile forming the phosphohistidine-enzyme intermediate during
RT   catalysis.";
RL   J. Biol. Chem. 277:32837-32842(2002).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-96.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [8]
RP   VARIANT GSD1A CYS-83.
RX   PubMed=8182131; DOI=10.1172/JCI117192;
RA   Lei K.J., Pan C.J., Shelly L.L., Liu J.L., Chou J.Y.;
RT   "Identification of mutations in the gene for glucose-6-phosphatase,
RT   the enzyme deficient in glycogen storage disease type 1a.";
RL   J. Clin. Invest. 93:1994-1999(1994).
RN   [9]
RP   VARIANTS GSD1A.
RX   PubMed=7573034;
RA   Lei K.-J., Chen Y.-T., Chen H., Wong L.-J.C., Liu J.-L.,
RA   McConkie-Rosell A., van Hove J.L.K., Ou H.C.-Y., Yeh N.J., Pan L.Y.,
RA   Chou J.Y.;
RT   "Genetic basis of glycogen storage disease type 1a: prevalent
RT   mutations at the glucose-6-phosphatase locus.";
RL   Am. J. Hum. Genet. 57:766-771(1995).
RN   [10]
RP   VARIANTS GSD1A CYS-83 AND GLY-166.
RX   PubMed=7623438; DOI=10.1007/BF00711368;
RA   Parvari R., Moses S., Hershkovitz E., Carmi R., Bashan N.;
RT   "Characterization of the mutations in the glucose-6-phosphatase gene
RT   in Israeli patients with glycogen storage disease type 1a: R83C in six
RT   Jews and a novel V166G mutation in a Muslim Arab.";
RL   J. Inherit. Metab. Dis. 18:21-27(1995).
RN   [11]
RP   VARIANT GSD1A ILE-83.
RX   PubMed=7655466; DOI=10.1093/hmg/4.6.1095;
RA   Hwu W.-L., Chuang S.-C., Tsai L.-P., Chang M.-H., Chuang S.-M.,
RA   Wang T.-R.;
RT   "Glucose-6-phosphatase gene G327A mutation is common in Chinese
RT   patients with glycogen storage disease type Ia.";
RL   Hum. Mol. Genet. 4:1095-1096(1995).
RN   [12]
RP   VARIANTS GSD1A HIS-83 AND ASN-341.
RX   PubMed=9001800;
RA   Lee W.J., Lee H.M., Chi C.S., Shu S.G., Lin L.Y., Lin W.H.;
RT   "Genetic analysis of the glucose-6-phosphatase mutation of type 1a
RT   glycogen storage disease in a Chinese family.";
RL   Clin. Genet. 50:206-211(1996).
RN   [13]
RP   VARIANTS GSD1A VAL-38; ARG-77; LYS-110; THR-124; GLU-184; ARG-188 AND
RP   PRO-211.
RX   PubMed=8733042; DOI=10.1136/jmg.33.5.358;
RA   Chevalier-Porst F., Bozon D., Bonardot A.-M., Bruni N., Mithieux G.,
RA   Mathieu M., Maire I.;
RT   "Mutation analysis in 24 French patients with glycogen storage disease
RT   type 1a.";
RL   J. Med. Genet. 33:358-360(1996).
RN   [14]
RP   VARIANTS GSD1A CYS-83 AND GLY-166.
RX   PubMed=9332655;
RX   DOI=10.1002/(SICI)1096-8628(19971031)72:3<286::AID-AJMG6>3.0.CO;2-P;
RA   Parvari R., Lei K.J., Bashan N., Hershkovitz E., Korman S.H.,
RA   Barash V., Lerman-Sagie T., Mandel H., Chou J.Y., Moses S.W.;
RT   "Glycogen storage disease type 1a in Israel: biochemical, clinical,
RT   and mutational studies.";
RL   Am. J. Med. Genet. 72:286-290(1997).
RN   [15]
RP   VARIANTS GSD1A CYS-83; GLN-170 AND TRP-270.
RX   PubMed=9700612; DOI=10.1023/A:1005339616074;
RA   Huener G., Podskarbi T., Schuetz M., Baykal T., Sarbat G., Shin Y.S.,
RA   Demirkol M.;
RT   "Molecular aspects of glycogen storage disease type Ia in Turkish
RT   patients: a novel mutation in the glucose-6-phosphatase gene.";
RL   J. Inherit. Metab. Dis. 21:445-446(1998).
RN   [16]
RP   VARIANT GSD1A ARG-68.
RX   PubMed=9700613; DOI=10.1023/A:1005391600145;
RA   Sartorato E.L., Reis F.C., Norato D.Y.J., Hackel C.;
RT   "A novel mutation in a Brazilian patient with glycogen storage disease
RT   type 1a.";
RL   J. Inherit. Metab. Dis. 21:447-447(1998).
RN   [17]
RP   VARIANTS GSD1A CYS-83 AND LYS-264.
RX   PubMed=9506659; DOI=10.1016/S0022-3476(98)70463-9;
RA   Keller K.M., Schuetz M., Podskarbi T., Bindl L., Lentze M.J.,
RA   Shin Y.S.;
RT   "A new mutation of the glucose-6-phosphatase gene in a 4-year-old girl
RT   with oligosymptomatic glycogen storage disease type 1a.";
RL   J. Pediatr. 132:360-361(1998).
RN   [18]
RP   VARIANTS GSD1A VAL-266 AND PHE-338.
RX   PubMed=10094563;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:2<173::AID-HUMU19>3.0.CO;2-E;
RA   Rake J.P., ten Berge A.M., Verlind E., Visser G., Niezen-Koning K.E.,
RA   Buys C.H.C.M., Smit G.P., Scheffer H.;
RT   "Glycogen storage disease type Ia: four novel mutations (175delGG,
RT   R170X, G266V and V338F) identified.";
RL   Hum. Mutat. 13:173-173(1999).
RN   [19]
RP   VARIANTS GSD1A PRO-54 AND ILE-108.
RX   PubMed=10447271;
RX   DOI=10.1002/(SICI)1098-1004(1999)14:1<91::AID-HUMU21>3.0.CO;2-B;
RA   Trioche P., Francoual J., Chalas J., Capel L., Bernard O., Labrune P.;
RT   "Identification of three novel mutations (Q54P, W70X and T108I) in the
RT   glucose-6-phosphatase gene of patients with glycogen storage disease
RT   type Ia.";
RL   Hum. Mutat. 14:91-91(1999).
RN   [20]
RP   VARIANTS GSD1A VAL-38; ARG-63; CYS-83; VAL-184; ARG-222; VAL-270;
RP   CYS-295; PRO-298 AND PHE-338.
RX   PubMed=10070617; DOI=10.1023/A:1005495131118;
RA   Stroppiano M., Regis S., DiRocco M., Caroli F., Gandullia P.,
RA   Gatti R.;
RT   "Mutations in the glucose-6-phosphatase gene of 53 Italian patients
RT   with glycogen storage disease type Ia.";
RL   J. Inherit. Metab. Dis. 22:43-49(1999).
RN   [21]
RP   VARIANTS GSD1A HIS-83; ASP-122; PRO-179 AND LEU-257.
RX   PubMed=10748407;
RX   DOI=10.1002/(SICI)1096-8628(20000313)91:2<107::AID-AJMG5>3.0.CO;2-Y;
RA   Akanuma J., Nishigaki T., Fujii K., Matsubara Y., Inui K.,
RA   Takahashi K., Kure S., Suzuki Y., Ohura T., Miyabayashi S., Ogawa E.,
RA   Iinuma K., Okada S., Narisawa K.;
RT   "Glycogen storage disease type Ia: molecular diagnosis of 51 Japanese
RT   patients and characterization of splicing mutations by analysis of
RT   ectopically transcribed mRNA from lymphoblastoid cells.";
RL   Am. J. Med. Genet. 91:107-112(2000).
RN   [22]
RP   VARIANTS GSD1A ARG-20; ARG-81; LEU-156 AND ASP-188.
RX   PubMed=10612834;
RX   DOI=10.1002/(SICI)1098-1004(200001)15:1<115::AID-HUMU23>3.0.CO;2-W;
RA   Seydewitz H.H., Matern D.;
RT   "Molecular genetic analysis of 40 patients with glycogen storage
RT   disease type Ia: 100% mutation detection rate and 5 novel mutations.";
RL   Hum. Mutat. 15:115-116(2000).
RN   [23]
RP   VARIANT GSD1A ALA-16.
RX   PubMed=10738005;
RX   DOI=10.1002/(SICI)1098-1004(200004)15:4<390::AID-HUMU32>3.0.CO;2-N;
RA   Wu M.-C., Tsai F.-J., Lee C.-C., Lin S.-P., Wu J.-Y.;
RT   "Identification of a novel missense mutation (T16A) in the glucose-6-
RT   phosphatase gene in a Taiwan Chinese patient with glycogen storage
RT   disease Ia (von Gierke disease).";
RL   Hum. Mutat. 15:390-390(2000).
RN   [24]
RP   VARIANTS GSD1A ASN-76; ARG-77; CYS-83; ALA-166; ARG-188 AND CYS-295.
RX   PubMed=10874313;
RX   DOI=10.1002/1098-1004(200007)16:1<89::AID-HUMU17>3.3.CO;2-1;
RA   Kozak L., Francova H., Hrabincova E., Stastna S., Peskova K.,
RA   Elleder M.;
RT   "Identification of mutations in the glucose-6-phosphatase gene in
RT   Czech and Slovak patients with glycogen storage disease type Ia,
RT   including novel mutations K76N, V166A and 540del5.";
RL   Hum. Mutat. 16:89-89(2000).
RN   [25]
RP   VARIANTS GSD1A ARG-5; VAL-38; PRO-54; CYS-83; ILE-108; LYS-110;
RP   ILE-111; GLU-184; ARG-188; THR-241; ARG-270; VAL-270; LEU-322; PHE-327
RP   DEL AND PHE-338.
RX   PubMed=11058903;
RX   DOI=10.1002/1098-1004(200011)16:5<444::AID-HUMU10>3.0.CO;2-F;
RA   Trioche P., Francoual J., Chalas J., Capel L., Lindenbaum A.,
RA   Odievre M., Labrune P.;
RT   "Genetic heterogeneity of glycogen storage disease type Ia in France:
RT   a study of 48 patients.";
RL   Hum. Mutat. 16:444-444(2000).
RN   [26]
RP   VARIANT GSD1A LEU-119.
RX   PubMed=11058910;
RX   DOI=10.1002/1098-1004(200011)16:5<447::AID-HUMU17>3.0.CO;2-M;
RA   Wu M.-C., Tsai F.-J., Lee C.-C., Tsai C.-H., Wu J.-Y.;
RT   "A novel missense mutation (H119L) identified in a Taiwan Chinese
RT   family with glycogen storage disease Ia (von Gierke disease).";
RL   Hum. Mutat. 16:447-447(2000).
RN   [27]
RP   VARIANT GSD1A ARG-188.
RX   PubMed=10960498; DOI=10.1203/00006450-200009000-00011;
RA   Weston B.W., Lin J.L., Muenzer J., Cameron H.S., Arnold R.R.,
RA   Seydewitz H.H., Mayatepek E., Van Schaftingen E., Veiga-da-Cunha M.,
RA   Matern D., Chen Y.T.;
RT   "Glucose-6-phosphatase mutation G188R confers an atypical glycogen
RT   storage disease type 1b phenotype.";
RL   Pediatr. Res. 48:329-334(2000).
RN   [28]
RP   VARIANTS GSD1A ARG-20; VAL-38; PRO-65; ARG-68; ARG-77; ARG-81; CYS-83;
RP   HIS-83; LYS-110; LEU-113; LEU-156; GLN-170; CYS-177; SER-178; ARG-188;
RP   SER-188; ARG-236; PRO-265; VAL-270; PHE-327 DEL AND ARG-345.
RX   PubMed=12373566; DOI=10.1007/BF02679989;
RA   Matern D., Seydewitz H.H., Bali D., Lang C., Chen Y.-T.;
RT   "Glycogen storage disease type I: diagnosis and phenotype/genotype
RT   correlation.";
RL   Eur. J. Pediatr. 161:S10-S19(2002).
RN   [29]
RP   VARIANT GSD1A CYS-83.
RX   PubMed=15316959; DOI=10.1002/ajmg.a.30232;
RA   Ekstein J., Rubin B.Y., Anderson S.L., Weinstein D.A., Bach G.,
RA   Abeliovich D., Webb M., Risch N.;
RT   "Mutation frequencies for glycogen storage disease Ia in the Ashkenazi
RT   Jewish population.";
RL   Am. J. Med. Genet. A 129:162-164(2004).
RN   [30]
RP   VARIANTS GSD1A ASP-122; ALA-178 AND ILE-255.
RX   PubMed=15151508; DOI=10.1111/j.1399-0004.2004.00260.x;
RA   Ki C.S., Han S.H., Kim H.J., Lee S.G., Kim E.J., Kim J.W., Choe Y.H.,
RA   Seo J.K., Chang Y.J., Park J.Y.;
RT   "Mutation spectrum of the glucose-6-phosphatase gene and its
RT   implication in molecular diagnosis of Korean patients with glycogen
RT   storage disease type Ia.";
RL   Clin. Genet. 65:487-489(2004).
RN   [31]
RP   VARIANTS GSD1A ARG-16; PRO-54; CYS-83 AND CYS-209, AND
RP   CHARACTERIZATION OF VARIANTS GSD1A ARG-16 AND CYS-209.
RX   PubMed=15542400; DOI=10.1016/j.ymgme.2004.06.010;
RA   Angaroni C.J., de Kremer R.D., Argarana C.E., Paschini-Capra A.E.,
RA   Giner-Ayala A.N., Pezza R.J., Pan C.-J., Chou J.Y.;
RT   "Glycogen storage disease type Ia in Argentina: two novel glucose-6-
RT   phosphatase mutations affecting protein stability.";
RL   Mol. Genet. Metab. 83:276-279(2004).
RN   [32]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-116.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Hydrolyzes glucose-6-phosphate to glucose in the
CC       endoplasmic reticulum. Forms with the glucose-6-phosphate
CC       transporter (SLC37A4/G6PT) the complex responsible for glucose
CC       production through glycogenolysis and gluconeogenesis. Hence, it
CC       is the key enzyme in homeostatic regulation of blood glucose
CC       levels.
CC   -!- CATALYTIC ACTIVITY: D-glucose 6-phosphate + H(2)O = D-glucose +
CC       phosphate.
CC   -!- PATHWAY: Carbohydrate biosynthesis; gluconeogenesis.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P35575-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P35575-2; Sequence=VSP_047558, VSP_047559;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Glycogen storage disease 1A (GSD1A) [MIM:232200]: A
CC       metabolic disorder characterized by impairment of terminal steps
CC       of glycogenolysis and gluconeogenesis. Patients manifest a wide
CC       range of clinical symptoms and biochemical abnormalities,
CC       including hypoglycemia, severe hepatomegaly due to excessive
CC       accumulation of glycogen, kidney enlargement, growth retardation,
CC       lactic acidemia, hyperlipidemia, and hyperuricemia.
CC       {ECO:0000269|PubMed:10070617, ECO:0000269|PubMed:10094563,
CC       ECO:0000269|PubMed:10447271, ECO:0000269|PubMed:10612834,
CC       ECO:0000269|PubMed:10738005, ECO:0000269|PubMed:10748407,
CC       ECO:0000269|PubMed:10874313, ECO:0000269|PubMed:10960498,
CC       ECO:0000269|PubMed:11058903, ECO:0000269|PubMed:11058910,
CC       ECO:0000269|PubMed:12373566, ECO:0000269|PubMed:15151508,
CC       ECO:0000269|PubMed:15316959, ECO:0000269|PubMed:15542400,
CC       ECO:0000269|PubMed:7573034, ECO:0000269|PubMed:7623438,
CC       ECO:0000269|PubMed:7655466, ECO:0000269|PubMed:8182131,
CC       ECO:0000269|PubMed:8733042, ECO:0000269|PubMed:9001800,
CC       ECO:0000269|PubMed:9332655, ECO:0000269|PubMed:9506659,
CC       ECO:0000269|PubMed:9700612, ECO:0000269|PubMed:9700613}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the glucose-6-phosphatase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAG64735.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U01120; AAA16222.1; -; mRNA.
DR   EMBL; AK303771; BAG64735.1; ALT_INIT; mRNA.
DR   EMBL; AK313982; BAG36695.1; -; mRNA.
DR   EMBL; AC016889; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC130478; AAI30479.1; -; mRNA.
DR   EMBL; BC136369; AAI36370.1; -; mRNA.
DR   CCDS; CCDS11446.1; -. [P35575-1]
DR   CCDS; CCDS59291.1; -. [P35575-2]
DR   PIR; A48251; A48251.
DR   RefSeq; NP_000142.2; NM_000151.3. [P35575-1]
DR   RefSeq; NP_001257326.1; NM_001270397.1. [P35575-2]
DR   UniGene; Hs.212293; -.
DR   UniGene; Hs.742566; -.
DR   ProteinModelPortal; P35575; -.
DR   BioGrid; 108813; 3.
DR   IntAct; P35575; 3.
DR   STRING; 9606.ENSP00000253801; -.
DR   BindingDB; P35575; -.
DR   ChEMBL; CHEMBL2282; -.
DR   DEPOD; P35575; -.
DR   iPTMnet; P35575; -.
DR   PhosphoSitePlus; P35575; -.
DR   BioMuta; G6PC; -.
DR   DMDM; 206729864; -.
DR   PaxDb; P35575; -.
DR   PeptideAtlas; P35575; -.
DR   PRIDE; P35575; -.
DR   DNASU; 2538; -.
DR   Ensembl; ENST00000253801; ENSP00000253801; ENSG00000131482. [P35575-1]
DR   Ensembl; ENST00000592383; ENSP00000465958; ENSG00000131482. [P35575-2]
DR   GeneID; 2538; -.
DR   KEGG; hsa:2538; -.
DR   UCSC; uc002icb.3; human. [P35575-1]
DR   CTD; 2538; -.
DR   DisGeNET; 2538; -.
DR   GeneCards; G6PC; -.
DR   GeneReviews; G6PC; -.
DR   HGNC; HGNC:4056; G6PC.
DR   HPA; HPA052324; -.
DR   MalaCards; G6PC; -.
DR   MIM; 232200; phenotype.
DR   MIM; 613742; gene.
DR   neXtProt; NX_P35575; -.
DR   OpenTargets; ENSG00000131482; -.
DR   Orphanet; 79258; Glycogen storage disease due to glucose-6-phosphatase deficiency type a.
DR   PharmGKB; PA28468; -.
DR   eggNOG; ENOG410IDXG; Eukaryota.
DR   eggNOG; ENOG4110AJ7; LUCA.
DR   GeneTree; ENSGT00510000046465; -.
DR   HOGENOM; HOG000264239; -.
DR   HOVERGEN; HBG003560; -.
DR   InParanoid; P35575; -.
DR   KO; K01084; -.
DR   OMA; YLQVNYQ; -.
DR   OrthoDB; EOG091G0AXF; -.
DR   PhylomeDB; P35575; -.
DR   TreeFam; TF324388; -.
DR   BioCyc; MetaCyc:HS05538-MONOMER; -.
DR   BRENDA; 3.1.3.9; 2681.
DR   Reactome; R-HSA-70153; Glucose transport.
DR   SABIO-RK; P35575; -.
DR   SIGNOR; P35575; -.
DR   UniPathway; UPA00138; -.
DR   ChiTaRS; G6PC; human.
DR   GeneWiki; G6PC; -.
DR   GenomeRNAi; 2538; -.
DR   PRO; PR:P35575; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000131482; -.
DR   CleanEx; HS_G6PC; -.
DR   ExpressionAtlas; P35575; baseline and differential.
DR   Genevisible; P35575; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; TAS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0004346; F:glucose-6-phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0042301; F:phosphate ion binding; IMP:UniProtKB.
DR   GO; GO:0016773; F:phosphotransferase activity, alcohol group as acceptor; IEA:Ensembl.
DR   GO; GO:0042632; P:cholesterol homeostasis; IEA:Ensembl.
DR   GO; GO:0006094; P:gluconeogenesis; IMP:UniProtKB.
DR   GO; GO:0051156; P:glucose 6-phosphate metabolic process; IBA:GO_Central.
DR   GO; GO:0042593; P:glucose homeostasis; IMP:UniProtKB.
DR   GO; GO:0015758; P:glucose transport; TAS:Reactome.
DR   GO; GO:0015760; P:glucose-6-phosphate transport; IEA:Ensembl.
DR   GO; GO:0005980; P:glycogen catabolic process; IEA:Ensembl.
DR   GO; GO:0005977; P:glycogen metabolic process; TAS:ProtInc.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0046838; P:phosphorylated carbohydrate dephosphorylation; IEA:Ensembl.
DR   GO; GO:0010468; P:regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0032094; P:response to food; IEA:Ensembl.
DR   GO; GO:0008202; P:steroid metabolic process; IEA:Ensembl.
DR   GO; GO:0006641; P:triglyceride metabolic process; IEA:Ensembl.
DR   GO; GO:0046415; P:urate metabolic process; IEA:Ensembl.
DR   Gene3D; 1.20.144.10; -; 1.
DR   InterPro; IPR016275; Glucose-6-phosphatase.
DR   InterPro; IPR000326; P_Acid_Pase_2/haloperoxidase.
DR   Pfam; PF01569; PAP2; 1.
DR   PIRSF; PIRSF000905; Glucose-6-phosphatase; 1.
DR   SMART; SM00014; acidPPc; 1.
DR   SUPFAM; SSF48317; SSF48317; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Gluconeogenesis; Glycogen storage disease;
KW   Glycoprotein; Hydrolase; Membrane; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    357       Glucose-6-phosphatase.
FT                                /FTId=PRO_0000087413.
FT   TOPO_DOM      1     28       Lumenal. {ECO:0000255}.
FT   TRANSMEM     29     49       Helical. {ECO:0000255}.
FT   TOPO_DOM     50     60       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     61     81       Helical. {ECO:0000255}.
FT   TOPO_DOM     82    117       Lumenal. {ECO:0000255}.
FT   TRANSMEM    118    138       Helical. {ECO:0000255}.
FT   TOPO_DOM    139    147       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    148    168       Helical. {ECO:0000255}.
FT   TOPO_DOM    169    179       Lumenal. {ECO:0000255}.
FT   TRANSMEM    180    202       Helical. {ECO:0000255}.
FT   TOPO_DOM    203    209       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    210    230       Helical. {ECO:0000255}.
FT   TOPO_DOM    231    254       Lumenal. {ECO:0000255}.
FT   TRANSMEM    255    275       Helical. {ECO:0000255}.
FT   TOPO_DOM    276    291       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    292    312       Helical. {ECO:0000255}.
FT   TOPO_DOM    313    320       Lumenal. {ECO:0000255}.
FT   TRANSMEM    321    341       Helical. {ECO:0000255}.
FT   TOPO_DOM    342    357       Cytoplasmic. {ECO:0000255}.
FT   ACT_SITE    119    119       Proton donor. {ECO:0000255}.
FT   ACT_SITE    176    176       Nucleophile.
FT                                {ECO:0000269|PubMed:12093795}.
FT   BINDING      83     83       Substrate. {ECO:0000255}.
FT   BINDING     170    170       Substrate. {ECO:0000255}.
FT   CARBOHYD     96     96       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:9705299}.
FT   VAR_SEQ     115    175       SPSGHAMGTAGVYYVMVTSTLSIFQGKIKPTYRFRCLNVIL
FT                                WLGFWAVQLNVCLSRIYLAA -> KDKADLQISVLECHFVV
FT                                GILGCAAECLSVTNLPCCSFSSSSCCWSPVRHCCCRNFQPH
FT                                PQH (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047558.
FT   VAR_SEQ     176    356       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047559.
FT   VARIANT       5      5       M -> R (in GSD1A).
FT                                {ECO:0000269|PubMed:11058903}.
FT                                /FTId=VAR_046249.
FT   VARIANT      16     16       T -> A (in GSD1A; dbSNP:rs761839506).
FT                                {ECO:0000269|PubMed:10738005}.
FT                                /FTId=VAR_046250.
FT   VARIANT      16     16       T -> R (in GSD1A; complete loss of
FT                                activity and reduced enzyme stability).
FT                                {ECO:0000269|PubMed:15542400}.
FT                                /FTId=VAR_046251.
FT   VARIANT      20     20       Q -> R (in GSD1A).
FT                                {ECO:0000269|PubMed:10612834,
FT                                ECO:0000269|PubMed:12373566}.
FT                                /FTId=VAR_009202.
FT   VARIANT      38     38       D -> V (in GSD1A; dbSNP:rs104894565).
FT                                {ECO:0000269|PubMed:10070617,
FT                                ECO:0000269|PubMed:11058903,
FT                                ECO:0000269|PubMed:12373566,
FT                                ECO:0000269|PubMed:8733042}.
FT                                /FTId=VAR_005237.
FT   VARIANT      54     54       Q -> P (in GSD1A).
FT                                {ECO:0000269|PubMed:10447271,
FT                                ECO:0000269|PubMed:11058903,
FT                                ECO:0000269|PubMed:15542400}.
FT                                /FTId=VAR_009203.
FT   VARIANT      63     63       W -> R (in GSD1A).
FT                                {ECO:0000269|PubMed:10070617}.
FT                                /FTId=VAR_046252.
FT   VARIANT      65     65       A -> P (in GSD1A).
FT                                {ECO:0000269|PubMed:12373566}.
FT                                /FTId=VAR_046253.
FT   VARIANT      68     68       G -> R (in GSD1A).
FT                                {ECO:0000269|PubMed:12373566,
FT                                ECO:0000269|PubMed:9700613}.
FT                                /FTId=VAR_046254.
FT   VARIANT      76     76       K -> N (in GSD1A; loss of catalytic
FT                                activity). {ECO:0000269|PubMed:10874313,
FT                                ECO:0000269|PubMed:12093795}.
FT                                /FTId=VAR_046255.
FT   VARIANT      77     77       W -> R (in GSD1A; dbSNP:rs104894566).
FT                                {ECO:0000269|PubMed:10874313,
FT                                ECO:0000269|PubMed:12373566,
FT                                ECO:0000269|PubMed:8733042}.
FT                                /FTId=VAR_005238.
FT   VARIANT      81     81       G -> R (in GSD1A; dbSNP:rs756632286).
FT                                {ECO:0000269|PubMed:10612834,
FT                                ECO:0000269|PubMed:12373566}.
FT                                /FTId=VAR_009204.
FT   VARIANT      83     83       R -> C (in GSD1A; complete loss of
FT                                activity; prevalent mutation in Ashkenazi
FT                                Jewish population; dbSNP:rs1801175).
FT                                {ECO:0000269|PubMed:10070617,
FT                                ECO:0000269|PubMed:10874313,
FT                                ECO:0000269|PubMed:11058903,
FT                                ECO:0000269|PubMed:12093795,
FT                                ECO:0000269|PubMed:12373566,
FT                                ECO:0000269|PubMed:15316959,
FT                                ECO:0000269|PubMed:15542400,
FT                                ECO:0000269|PubMed:7623438,
FT                                ECO:0000269|PubMed:8182131,
FT                                ECO:0000269|PubMed:9332655,
FT                                ECO:0000269|PubMed:9506659,
FT                                ECO:0000269|PubMed:9700612}.
FT                                /FTId=VAR_005239.
FT   VARIANT      83     83       R -> H (in GSD1A; dbSNP:rs1801176).
FT                                {ECO:0000269|PubMed:10748407,
FT                                ECO:0000269|PubMed:12373566,
FT                                ECO:0000269|PubMed:9001800}.
FT                                /FTId=VAR_005240.
FT   VARIANT      83     83       R -> I (in GSD1A).
FT                                {ECO:0000269|PubMed:7655466}.
FT                                /FTId=VAR_005241.
FT   VARIANT     108    108       T -> I (in GSD1A).
FT                                {ECO:0000269|PubMed:10447271,
FT                                ECO:0000269|PubMed:11058903}.
FT                                /FTId=VAR_009205.
FT   VARIANT     110    110       E -> K (in GSD1A; dbSNP:rs104894567).
FT                                {ECO:0000269|PubMed:11058903,
FT                                ECO:0000269|PubMed:12373566,
FT                                ECO:0000269|PubMed:8733042}.
FT                                /FTId=VAR_005242.
FT   VARIANT     111    111       T -> I (in GSD1A).
FT                                {ECO:0000269|PubMed:11058903}.
FT                                /FTId=VAR_046256.
FT   VARIANT     113    113       P -> L (in GSD1A).
FT                                {ECO:0000269|PubMed:12373566}.
FT                                /FTId=VAR_046257.
FT   VARIANT     116    116       P -> L (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035922.
FT   VARIANT     119    119       H -> L (in GSD1A).
FT                                {ECO:0000269|PubMed:11058910}.
FT                                /FTId=VAR_046258.
FT   VARIANT     122    122       G -> D (in GSD1A; dbSNP:rs759982943).
FT                                {ECO:0000269|PubMed:10748407,
FT                                ECO:0000269|PubMed:15151508}.
FT                                /FTId=VAR_046259.
FT   VARIANT     124    124       A -> T (in GSD1A; dbSNP:rs104894568).
FT                                {ECO:0000269|PubMed:8733042}.
FT                                /FTId=VAR_005243.
FT   VARIANT     156    156       W -> L (in GSD1A).
FT                                {ECO:0000269|PubMed:10612834,
FT                                ECO:0000269|PubMed:12373566}.
FT                                /FTId=VAR_009206.
FT   VARIANT     166    166       V -> A (in GSD1A).
FT                                {ECO:0000269|PubMed:10874313}.
FT                                /FTId=VAR_046260.
FT   VARIANT     166    166       V -> G (in GSD1A; complete loss of
FT                                activity; dbSNP:rs104894571).
FT                                {ECO:0000269|PubMed:7623438,
FT                                ECO:0000269|PubMed:9332655}.
FT                                /FTId=VAR_005244.
FT   VARIANT     170    170       R -> Q (in GSD1A; loss of catalytic
FT                                activity; dbSNP:rs750470654).
FT                                {ECO:0000269|PubMed:12093795,
FT                                ECO:0000269|PubMed:12373566,
FT                                ECO:0000269|PubMed:9700612}.
FT                                /FTId=VAR_046261.
FT   VARIANT     177    177       F -> C (in GSD1A).
FT                                {ECO:0000269|PubMed:12373566}.
FT                                /FTId=VAR_046262.
FT   VARIANT     178    178       P -> A (in GSD1A; dbSNP:rs763543607).
FT                                {ECO:0000269|PubMed:15151508}.
FT                                /FTId=VAR_065164.
FT   VARIANT     178    178       P -> S (in GSD1A).
FT                                {ECO:0000269|PubMed:12373566}.
FT                                /FTId=VAR_046263.
FT   VARIANT     179    179       H -> P (in GSD1A).
FT                                {ECO:0000269|PubMed:10748407}.
FT                                /FTId=VAR_046264.
FT   VARIANT     184    184       G -> E (in GSD1A; dbSNP:rs104894569).
FT                                {ECO:0000269|PubMed:11058903,
FT                                ECO:0000269|PubMed:8733042}.
FT                                /FTId=VAR_005245.
FT   VARIANT     184    184       G -> V (in GSD1A).
FT                                {ECO:0000269|PubMed:10070617}.
FT                                /FTId=VAR_046265.
FT   VARIANT     188    188       G -> D (in GSD1A; dbSNP:rs760981149).
FT                                {ECO:0000269|PubMed:10612834}.
FT                                /FTId=VAR_009207.
FT   VARIANT     188    188       G -> R (in GSD1A; complete loss of
FT                                activity; dbSNP:rs80356482).
FT                                {ECO:0000269|PubMed:10874313,
FT                                ECO:0000269|PubMed:10960498,
FT                                ECO:0000269|PubMed:11058903,
FT                                ECO:0000269|PubMed:12373566,
FT                                ECO:0000269|PubMed:8733042}.
FT                                /FTId=VAR_005246.
FT   VARIANT     188    188       G -> S (in GSD1A; dbSNP:rs80356482).
FT                                {ECO:0000269|PubMed:12373566}.
FT                                /FTId=VAR_046266.
FT   VARIANT     209    209       Y -> C (in GSD1A; complete loss of
FT                                activity and reduced enzyme stability).
FT                                {ECO:0000269|PubMed:15542400}.
FT                                /FTId=VAR_046268.
FT   VARIANT     211    211       L -> P (in GSD1A).
FT                                {ECO:0000269|PubMed:8733042}.
FT                                /FTId=VAR_005247.
FT   VARIANT     222    222       G -> R (in GSD1A).
FT                                {ECO:0000269|PubMed:10070617}.
FT                                /FTId=VAR_005248.
FT   VARIANT     236    236       W -> R (in GSD1A).
FT                                {ECO:0000269|PubMed:12373566}.
FT                                /FTId=VAR_046269.
FT   VARIANT     241    241       A -> T (in GSD1A).
FT                                {ECO:0000269|PubMed:11058903}.
FT                                /FTId=VAR_046270.
FT   VARIANT     255    255       T -> I (in GSD1A).
FT                                {ECO:0000269|PubMed:15151508}.
FT                                /FTId=VAR_065165.
FT   VARIANT     257    257       P -> L (in GSD1A).
FT                                {ECO:0000269|PubMed:10748407}.
FT                                /FTId=VAR_046271.
FT   VARIANT     264    264       N -> K (in GSD1A).
FT                                {ECO:0000269|PubMed:9506659}.
FT                                /FTId=VAR_046272.
FT   VARIANT     265    265       L -> P (in GSD1A).
FT                                {ECO:0000269|PubMed:12373566}.
FT                                /FTId=VAR_046273.
FT   VARIANT     266    266       G -> V (in GSD1A).
FT                                {ECO:0000269|PubMed:10094563}.
FT                                /FTId=VAR_005249.
FT   VARIANT     270    270       G -> R (in GSD1A).
FT                                {ECO:0000269|PubMed:11058903}.
FT                                /FTId=VAR_046274.
FT   VARIANT     270    270       G -> V (in GSD1A; dbSNP:rs80356483).
FT                                {ECO:0000269|PubMed:10070617,
FT                                ECO:0000269|PubMed:11058903,
FT                                ECO:0000269|PubMed:12373566}.
FT                                /FTId=VAR_005250.
FT   VARIANT     270    270       G -> W (in GSD1A).
FT                                {ECO:0000269|PubMed:9700612}.
FT                                /FTId=VAR_046275.
FT   VARIANT     295    295       R -> C (in GSD1A; dbSNP:rs104894563).
FT                                {ECO:0000269|PubMed:10070617,
FT                                ECO:0000269|PubMed:10874313}.
FT                                /FTId=VAR_005251.
FT   VARIANT     298    298       S -> P (in GSD1A; dbSNP:rs770003650).
FT                                {ECO:0000269|PubMed:10070617}.
FT                                /FTId=VAR_046276.
FT   VARIANT     322    322       F -> L (in GSD1A).
FT                                {ECO:0000269|PubMed:11058903}.
FT                                /FTId=VAR_046277.
FT   VARIANT     327    327       Missing (in GSD1A).
FT                                {ECO:0000269|PubMed:11058903,
FT                                ECO:0000269|PubMed:12373566}.
FT                                /FTId=VAR_005252.
FT   VARIANT     338    338       V -> F (in GSD1A; dbSNP:rs367727229).
FT                                {ECO:0000269|PubMed:10070617,
FT                                ECO:0000269|PubMed:10094563,
FT                                ECO:0000269|PubMed:11058903}.
FT                                /FTId=VAR_005253.
FT   VARIANT     341    341       I -> N (in GSD1A; dbSNP:rs387906505).
FT                                {ECO:0000269|PubMed:9001800}.
FT                                /FTId=VAR_005254.
FT   VARIANT     345    345       L -> R (in GSD1A).
FT                                {ECO:0000269|PubMed:12373566}.
FT                                /FTId=VAR_046278.
FT   MUTAGEN       9      9       H->A: Partial loss of catalytic activity.
FT                                {ECO:0000269|PubMed:12093795}.
FT   MUTAGEN      52     52       H->A: Partial loss of catalytic activity.
FT                                {ECO:0000269|PubMed:12093795}.
FT   MUTAGEN     119    119       H->A: Loss of catalytic activity.
FT                                {ECO:0000269|PubMed:12093795}.
FT   MUTAGEN     176    176       H->A: Loss of catalytic activity.
FT                                {ECO:0000269|PubMed:12093795}.
FT   MUTAGEN     179    179       H->A: Loss of catalytic activity.
FT                                {ECO:0000269|PubMed:12093795}.
FT   MUTAGEN     197    197       H->T: Partial loss of catalytic activity.
FT                                {ECO:0000269|PubMed:12093795}.
FT   MUTAGEN     252    252       H->A: Partial loss of catalytic activity.
FT                                {ECO:0000269|PubMed:12093795}.
FT   MUTAGEN     307    307       H->A: Partial loss of catalytic activity.
FT                                {ECO:0000269|PubMed:12093795}.
FT   MUTAGEN     353    353       H->A: Partial loss of catalytic activity.
FT                                {ECO:0000269|PubMed:12093795}.
FT   CONFLICT    109    109       C -> R (in Ref. 2; BAG64735).
FT                                {ECO:0000305}.
FT   CONFLICT    192    192       A -> T (in Ref. 1; AAA16222).
FT                                {ECO:0000305}.
SQ   SEQUENCE   357 AA;  40484 MW;  2FEA1C78928A9919 CRC64;
     MEEGMNVLHD FGIQSTHYLQ VNYQDSQDWF ILVSVIADLR NAFYVLFPIW FHLQEAVGIK
     LLWVAVIGDW LNLVFKWILF GQRPYWWVLD TDYYSNTSVP LIKQFPVTCE TGPGSPSGHA
     MGTAGVYYVM VTSTLSIFQG KIKPTYRFRC LNVILWLGFW AVQLNVCLSR IYLAAHFPHQ
     VVAGVLSGIA VAETFSHIHS IYNASLKKYF LITFFLFSFA IGFYLLLKGL GVDLLWTLEK
     AQRWCEQPEW VHIDTTPFAS LLKNLGTLFG LGLALNSSMY RESCKGKLSK WLPFRLSSIV
     ASLVLLHVFD SLKPPSQVEL VFYVLSFCKS AVVPLASVSV IPYCLAQVLG QPHKKSL
//
